4.8 Article

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

期刊

LANCET
卷 380, 期 9859, 页码 2224-2260

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(12)61766-8

关键词

-

资金

  1. Lundbeck
  2. Prana Biotechnology
  3. Abbott
  4. Amgen
  5. AstraZeneca
  6. George Clinical
  7. GlaxoSmithKline
  8. Novartis
  9. PepsiCo
  10. Pfizer
  11. Pharmacy Guild of Australia
  12. Roche
  13. Sanofi-Aventis
  14. Seervier
  15. Tanabe
  16. Australian Food and Grocery Council
  17. Bupa Australia
  18. Johnson and Johnson
  19. Merck Schering-Plough
  20. Servier
  21. United Healthcare Group
  22. Imperial College London (as PI) from the European Chemical Industry Council
  23. CONCAWE
  24. USEPA
  25. Shell Foundation
  26. Fight for Sight
  27. Australian National Health and Medical Research Council
  28. Monash University
  29. Cabrini Health
  30. Health Effects Institute
  31. William and Flora Hewlett Foundation
  32. Cancer Research UK
  33. Safework Australia
  34. Johns Hopkins Vaccine Initiative Scholarship
  35. WHO
  36. Parnassia Psychiatric Institute, The Hague, Netherlands
  37. Department of Psychiatry, University Medical Center Groningen, University of Groningen, Netherlands
  38. World Mental Health Japan
  39. Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]
  40. Intramural Research Program of the NIH (National Cancer Institute)
  41. Division of Intramural Research, National Institute of Environmental Health Sciences, USA
  42. Australian Research Council Future Fellowship
  43. National Health and Medical Research Council of Australia Senior Research Fellowship
  44. Munich Centre of Health Sciences
  45. Foundation for Alcohol Research and Education
  46. Victorian Department of Health
  47. Burke Global Health Fellowship
  48. Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation
  49. Vanderbilt Clinical and Translational Scholars Award
  50. Spanish Society of Rheumatology
  51. South African Research Chairs Initiative
  52. National Research Foundation
  53. National Institute of Environmental Health Sciences [ES00260]
  54. UK Medical Research Council (MRC)
  55. National Institute for Health Research Comprehensive Biomedical research Centre at Imperial College Healthcare NHS Trust
  56. Nutrition Impact Model Study (NIMS)
  57. Bill & Melinda Gates Foundation
  58. Spanish Rheumatology Association
  59. Institute of Bone and Joint Research
  60. University of Sydney
  61. Medical Research Council [MC_U137686857, G0801056B] Funding Source: researchfish
  62. Grants-in-Aid for Scientific Research [22390130, 21119003] Funding Source: KAKEN
  63. MRC [MC_U137686857] Funding Source: UKRI

向作者/读者索取更多资源

Background Quantification of the disease burden caused by different risks informs prevention by providing an account of health loss different to that provided by a disease-by-disease analysis. No complete revision of global disease burden caused by risk factors has been done since a comparative risk assessment in 2000, and no previous analysis has assessed changes in burden attributable to risk factors over time. Methods We estimated deaths and disability-adjusted life years (DALYs; sum of years lived with disability [YLD] and years of life lost [YLL]) attributable to the independent effects of 67 risk factors and clusters of risk factors for 21 regions in 1990 and 2010. We estimated exposure distributions for each year, region, sex, and age group, and relative risks per unit of exposure by systematically reviewing and synthesising published and unpublished data. We used these estimates, together with estimates of cause-specific deaths and DALYs from the Global Burden of Disease Study 2010, to calculate the burden attributable to each risk factor exposure compared with the theoretical-minimum-risk exposure. We incorporated uncertainty in disease burden, relative risks, and exposures into our estimates of attributable burden. Findings In 2010, the three leading risk factors for global disease burden were high blood pressure (7.0% [95% uncertainty interval 6.2-7.7] of global DALYs), tobacco smoking including second-hand smoke (6.3% [5.5-7.0]), and alcohol use (5.5% [5.0-5.9]). In 1990, the leading risks were childhood underweight (7.9% [6.8-9.4]), household air pollution from solid fuels (HAP; 7.0% [5.6-8.3]), and tobacco smoking including second-hand smoke (6.1% [5.4-6.8]). Dietary risk factors and physical inactivity collectively accounted for 10.0% (95% UI 9.2-10.8) of global DALYs in 2010, with the most prominent dietary risks being diets low in fruits and those high in sodium. Several risks that primarily affect childhood communicable diseases, including unimproved water and sanitation and childhood micronutrient deficiencies, fell in rank between 1990 and 2010, with unimproved water and sanitation accounting for 0.9% (0.4-1.6) of global DALYs in 2010. However, in most of sub-Saharan Africa childhood underweight, HAP, and non-exclusive and discontinued breastfeeding were the leading risks in 2010, while HAP was the leading risk in south Asia. The leading risk factor in Eastern Europe, most of Latin America, and southern sub-Saharan Africa in 2010 was alcohol use; in most of Asia, North Africa and Middle East, and central Europe it was high blood pressure. Despite declines, tobacco smoking including second-hand smoke remained the leading risk in high-income north America and western Europe. High body-mass index has increased globally and it is the leading risk in Australasia and southern Latin America, and also ranks high in other high-income regions, North Africa and Middle East, and Oceania. Interpretation Worldwide, the contribution of different risk factors to disease burden has changed substantially, with a shift away from risks for communicable diseases in children towards those for non-communicable diseases in adults. These changes are related to the ageing population, decreased mortality among children younger than 5 years, changes in cause-of-death composition, and changes in risk factor exposures. New evidence has led to changes in the magnitude of key risks including unimproved water and sanitation, vitamin A and zinc deficiencies, and ambient particulate matter pollution. The extent to which the epidemiological shift has occurred and what the leading risks currently are varies greatly across regions. In much of sub-Saharan Africa, the leading risks are still those associated with poverty and those that affect children.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据